Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$152M |
| 2 |
AT&T
T
|
+$119M |
| 3 |
Norfolk Southern
NSC
|
+$117M |
| 4 |
CSX Corp
CSX
|
+$115M |
| 5 |
Booking.com
BKNG
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$156M |
| 3 |
C.H. Robinson
CHRW
|
+$134M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$130M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.4% |
| 2 | Industrials | 9.75% |
| 3 | Financials | 7.9% |
| 4 | Consumer Staples | 7.89% |
| 5 | Healthcare | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
CALL
Western Union
WU
$2.28B
| $965K | 0.01% |
+50,000
| New | +$899K |
|
777
Kilroy Realty
KRC
$4.29B
| $933K | 0.01% |
15,077
-343,978
| -96% | -$19.3M |
|
778
Quanex
NX
$916M
| $927K | 0.01% |
+53,410
| New | +$942K |
|
779
Best Buy
BBY
$18.4B
| $925K | 0.01% |
+28,503
| New | +$864K |
|
|
XHR
780
Xenia Hotels & Resorts
XHR
$1.81B
| $923K | 0.01% |
59,104
-535,566
| -90% | -$7.92M |
|
781
Selective Insurance
SIGI
$5.52B
| $917K | 0.01% |
25,052
+14,200
| +131% | +$471K |
|
|
BRSL
782
Brightstar Lottery PLC
BRSL
$2.16B
| $913K | 0.01% |
50,000
-15,260
| -23% | -$232K |
|
|
P
783
PUT
DELISTED
Pandora Media Inc
P
| $895K | 0.01% |
+100,000
| New | +$981K |
|
784
MSCI
MSCI
$41.5B
| $892K | 0.01% |
+12,035
| New | +$832K |
|
785
KLA
KLAC
$237B
| $888K | 0.01% |
+121,900
| New | +$820K |
|
|
PKY
786
DELISTED
Parkway, Inc.
PKY
| $887K | 0.01% |
56,611
-362,969
| -87% | -$5.04M |
|
787
Lennox International
LII
$13.8B
| $885K | 0.01% |
+6,547
| New | +$810K |
|
|
TSRO
788
DELISTED
TESARO, Inc.
TSRO
| $884K | 0.01% |
+20,080
| New | +$806K |
|
|
CTXS
789
DELISTED
Citrix Systems Inc
CTXS
| $880K | 0.01% |
14,060
+9,506
| +209% | +$538K |
|
|
OB
790
DELISTED
Onebeacon Insurance Group Ltd
OB
| $876K | 0.01% |
68,815
+28,199
| +69% | +$360K |
|
791
Lowe's Companies
LOW
$122B
| $867K | 0.01% |
11,452
-661,052
| -98% | -$46.6M |
|
792
Motorola Solutions
MSI
$79.7B
| $861K | 0.01% |
+11,375
| New | +$769K |
|
793
Robert Half
RHI
$4.62B
| $859K | 0.01% |
18,450
+13,340
| +261% | +$559K |
|
794
CALL
Advanced Micro Devices
AMD
$746B
| $855K | 0.01% |
300,000
-3,000,000
| -91% | -$6.82M |
|
|
BLOX
795
CALL
DELISTED
Infoblox Inc
BLOX
| $855K | 0.01% |
+50,000
| New | +$799K |
|
796
Zillow
ZG
$8.53B
| $831K | ﹤0.01% |
+32,536
| New | +$724K |
|
|
SFR
797
DELISTED
Starwood Waypoint Homes
SFR
| $823K | ﹤0.01% |
33,259
-282,063
| -89% | -$6.31M |
|
798
Ocular Therapeutix
OCUL
$2.37B
| $821K | ﹤0.01% |
+85,000
| New | +$644K |
|
799
Equifax
EFX
$22.9B
| $819K | ﹤0.01% |
+7,170
| New | +$754K |
|
|
AAT
800
American Assets Trust
AAT
$1.41B
| $816K | ﹤0.01% |
20,436
-144,048
| -88% | -$5.37M |
|
Similar funds
Dmitry Balyasny's Q1 2016 Portfolio in Review
As of Q1 2016, Dmitry Balyasny held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dmitry Balyasny deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.
- Dmitry Balyasny's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
- Dmitry Balyasny added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
- Dmitry Balyasny's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
- Dmitry Balyasny fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
- Dmitry Balyasny's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
- Dmitry Balyasny opened 564 new positions and closed 526 in Q1 2016.
- Dmitry Balyasny's portfolio value rose 17% quarter-over-quarter to $16.8B.
Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.